Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 109 entries
View as:

Impact of the COVID-19 Infectious Epidemic on the Management of Oncology and Onco-hematology Patients and on the Psychological Consequences for Patients and Caregivers

Phase: N/A Priority: Normal
NCT ID: NCT04366154 Org: User:
Start: 04/15/20 End: 05/31/21 Due: 05/31/22

Establishment of Squamous Cell Organoids of the Head and Neck to Assess Their Response to Innovative Therapies

Phase: N/A Priority: Normal
NCT ID: NCT04261192 Org: User:
Start: 07/03/20 End: 02/28/31 Due: 02/28/32

Use of a Virtual Reality Cognitive Stimulation Programme for Breast Cancer Patients Wishing to Restart or Maintain a Professional Activity

Phase: N/A Priority: Normal
NCT ID: NCT06267014 Org: User:
Start: 05/23/24 End: 06/30/26 Due: 06/30/27

Telephone OncoGériatric Followed in the Management of Elderly Patients Treated for Cancer or Haematological Malignancy

Phase: N/A Priority: Normal
NCT ID: NCT02583035 Org: User:
Start: 02/28/15 End: 05/14/18 Due: 05/14/19

Optimize the Support of Patients in Pelvic Onco-gynecology Through Adapted Support Care in the Post-cancer Period. AFTERGYN Pilot Phase

Phase: N/A Priority: Normal
NCT ID: NCT05731661 Org: User:
Start: 01/09/23 End: 02/25/27 Due: 02/25/28

Evaluation of the Impact of Taking American Ginseng for 8 Weeks on Fatigue in Patients Treated for Localized Breast or Gynecological Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05241405 Org: User:
Start: 09/27/22 End: 09/30/27 Due: 09/30/28

Phase 3 Study Randomized Evaluating the Efficacy of Auriculotherapy in Patients With Musculoskeletal Pain by Aromatase Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT03096041 Org: User:
Start: 07/05/17 End: 12/31/25 Due: 12/31/26

Assessing the Value of a Dosage of Anti-cetuximab in the Therapeutic Management of Patients With Colon Cancer or Upper Aero-digestive Tract and Candidates for Treatment With Cetuximab

Phase: N/A Priority: Normal
NCT ID: NCT01436617 Org: User:
Start: 01/31/10 End: 03/31/13 Due: 03/31/14

Study of SIB-IMRT in Combination With 5-FU and Mitomycin-C Among Patients With Locally Advanced Anal Canal Cancer: Efficacy, Safety and Quality of Life

Phase: N/A Priority: Normal
NCT ID: NCT02701088 Org: User:
Start: 12/31/15 End: 12/31/24 Due: 12/31/25

Oral Care and Cancer: Assessing the Contribution of Training Healthcare Teams to Support the Oral Status of Patients Hospitalized in Palliative Situation

Phase: N/A Priority: Normal
NCT ID: NCT02208908 Org: User:
Start: 04/30/14 End: 06/30/15 Due: 06/30/16

A Study of ABT-263 as Single Agent in Women With Platinum Resistant/Refractory Recurrent Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02591095 Org: User:
Start: 01/31/16 End: 03/31/19 Due: 03/31/20

TALazoparib and Avelumab as Maintenance Therapy in Platinum-Sensitive Metastatic or Locally Advanced URothelial Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04678362 Org: User:
Start: 06/01/21 End: 12/31/25 Due: 12/31/26

Evaluation of States in Major Depressive Patients With Cancer, Hospitalized in a Hospital Palliative

Phase: N/A Priority: Normal
NCT ID: NCT01593085 Org: User:
Start: 04/30/12 End: 02/28/13 Due: 02/28/14

Impact of Web Application Support Versus Standard Management on Compliance With Adjuvant Hormone Therapy at 18 Months in Patients Treated for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04554927 Org: User:
Start: 09/03/20 End: 03/03/25 Due: 03/03/26

Prognostic Impact of the Neutrophil/Lymphocyte Ratio (NLR) in the Treatment of First-line Metastatic or Locally Advanced Breast Cancer Treated With CDK4/6 Inhibitor.

Phase: N/A Priority: Normal
NCT ID: NCT05303129 Org: User:
Start: 05/27/22 End: 12/17/24 Due: 12/17/25

Impact of Adjuvant Chemotherapy on the Quality of Life of Patients Treated for Stage II / III Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03466788 Org: User:
Start: 03/29/18 End: 03/28/19 Due: 03/28/20

Efficacy of Adapted Physical Activity on a Walking Platform in Elderly Patients HOspitalized for Cancer Surgery

Phase: N/A Priority: Normal
NCT ID: NCT06201884 Org: User:
Start: 03/15/24 End: 06/30/26 Due: 06/30/27

Phase II Study of Intensity Modulated Radiotherapy in Dose Painting for Sinus Carcinomas After Endoscopic Surgery

Phase: N/A Priority: Normal
NCT ID: NCT05943119 Org: User:
Start: 03/11/24 End: 03/31/29 Due: 03/31/30

Evaluation of the Efficacy of Low-dose Acetylsalicylic Acid on Diarrhea Induced by Anti-cancer Targeted Therapies.

Phase: N/A Priority: Normal
NCT ID: NCT02323516 Org: User:
Start: 12/31/14 End: 12/31/15 Due: 12/31/16

Stereotactic Radiotherapy for Cerebral Metastases with Recent Hemorrhagic Signal

Phase: N/A Priority: Normal
NCT ID: NCT03696680 Org: User:
Start: 01/16/19 End: 01/31/28 Due: 01/31/29

Neurocognitive Impact of Different Irradiation Modalities for Patients With Grade I-II Skull Base Meningioma:

Phase: N/A Priority: Normal
NCT ID: NCT06036706 Org: User:
Start: 09/13/23 End: 06/30/39 Due: 06/30/40

Benefit of Adding Cureety TechCare Telemonitoring to Usual Care During Injectable Anticancer Treatment

Phase: N/A Priority: Normal
NCT ID: NCT06371911 Org: User:
Start: 04/03/24 End: 12/03/24 Due: 12/03/25

Remotely Supervised Computerized Cognitive Stimulation to Reduce Post-chemotherapy Cognitive Difficulties in Patients Treated for Localized Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06027632 Org: User:
Start: 02/09/24 End: 03/31/29 Due: 03/31/30

Perioperative Treatment in Resectable Gastric Cancer With Spartalizumab (PDR001) in Combination With Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel (FLOT)

Phase: N/A Priority: Normal
NCT ID: NCT04736485 Org: User:
Start: 06/28/21 End: 03/31/27 Due: 03/31/28

Impact of Applying a Bandage Skin Hydrogel on the Pains of the Head and Neck in Patients With Cancer of Head and Neck Treated With Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01520701 Org: User:
Start: 02/29/12 End: 10/31/22 Due: 10/31/23